Commercial Banking

From startups to legacy brands, you're making your mark. We're here to help.

Innovation Economy
Fueling the success of early-stage startups, venture-backed and high-growth companies.
Midsize Businesses
Keep your company growing with custom banking solutions for middle market businesses and specialized industries.
Large Corporations
Innovative banking solutions tailored to corporations and specialized industries.
Commercial Real Estate
Capitalize on opportunities and prepare for challenges throughout the real estate cycle.
Community Impact Banking
When our communities succeed, we all succeed. Local businesses, organizations and community institutions need capital, expertise and connections to thrive.
International Banking
Power your business' global growth and operations at every stage.

Key Links

Credit and Financing

Prepare for future growth with customized loan services, succession planning and capital for business equipment.

Asset Based Lending
Enhance your liquidity and gain the flexibility to capitalize on growth opportunities.
Equipment Financing
Maximize working capital with flexible equipment and technology financing.
Trade & Working Capital
Experience our market-leading supply chain finance solutions that help buyers and suppliers meet their working capital, risk mitigation and cash flow objectives.
Syndicated Financing
Leverage customized loan syndication services from a dedicated resource.
Commercial Real Estate
Capitalize on opportunities and prepare for challenges throughout the real estate cycle.
Employee Stock Ownership Plans
Plan for your business’s future—and your employees’ futures too—with objective advice and financing.

Key Links

Institutional Investing

Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.

Institutional Investors
We put our long-tenured investment teams on the line to earn the trust of institutional investors.
Markets
Direct access to market leading liquidity harnessed through world-class research, tools, data and analytics.
Prime Services
Helping hedge funds, asset managers and institutional investors meet the demands of a rapidly evolving market.
Global Research
Leveraging cutting-edge technology and innovative tools to bring clients industry-leading analysis and investment advice.
Securities Services
Helping institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets.

Key Links

Investment Banking

Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.

Center for Carbon Transition
J.P. Morgan’s center of excellence that provides clients the data and firmwide expertise needed to navigate the challenges of transitioning to a low-carbon future.
Corporate Finance Advisory
Corporate Finance Advisory (“CFA”) is a global, multi-disciplinary solutions team specializing in structured M&A and capital markets. Learn more.
Development Finance Institution
Financing opportunities with anticipated development impact in emerging economies.
Sustainable Solutions
Offering ESG-related advisory and coordinating the firm's EMEA coverage of clients in emerging green economy sectors.
Mergers and Acquisitions
Bespoke M&A solutions on a global scale.
Capital Markets
Holistic coverage across capital markets.

Key Links

Private Bank

A uniquely elevated private banking experience shaped around you.

Banking
We have extensive personal and business banking resources that are fine-tuned to your specific needs.
Investing
We deliver tailored investing guidance and access to unique investment opportunities from world-class specialists.
Lending
We take a strategic approach to lending, working with you to craft the fight financing solutions matched to your goals.
Planning
No matter where you are in your life, or how complex your needs might be, we’re ready to provide a tailored approach to helping your reach your goals.

Wealth Management

Whether you want to invest on your own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.

Invest on your own
Unlimited $0 commission-free online stock, ETF and options trades with access to powerful tools to research, trade and manage your investments.
Work with our advisors
When you work with our advisors, you'll get a personalized financial strategy and investment portfolio built around your unique goals-backed by our industry-leading expertise.
Expertise for Substantial Wealth
Our Wealth Advisors & Wealth Partners leverage their experience and robust firm resources to deliver highly-personalized, comprehensive solutions across Banking, Lending, Investing, and Wealth Planning.

Key Links

About Us

We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.

Key Links

Outlook

Biopharma and medtech venture investments trend up in Q1

April 29, 2024

Our Biopharma and Medtech Licensing and Venture Reports explore upfront cash, mergers, acquisitions and other trends seen since January.

Browse by topic

Through the first quarter of 2024, venture investment has remained strong for biopharma and medtech companies.

The total amount of capital invested in biopharma therapeutics and discovery platforms increased approximately 33% compared to last quarter. Similarly, the total amount of deal value observed for medtech startups is nearly one-third of the total deal value for full-year 2023.

Additionally, despite challenges facing the broader exit environment, there was an uptick in the number of biopharma and medtech IPOs through the first quarter of the year.

J.P. Morgan’s biopharma therapeutics and medtech licensing reports explore the movement in each sector, offering insight on industry and investment trends that defined 2023 and will shed light onto the remainder of 2024. The reports, powered by DealForma, highlight:

Deal values in biopharma licensing partnerships
Trends in deal values for medical devices, diagnostics, digital health therapies and research tools
Venture investment amounts in therapeutic and platform companies
Investment and dealmaking on advanced therapies
IPO and M&A activity in each sector

Download the full reports to better understand these dealmaking trends.

BIOPHARMA REPORT

MEDTECH REPORT

Contributors

Kathryn McDonough

Head of Life Sciences, Innovation Economy, Commercial Banking, J.P. Morgan

Skip Kelly

Head of Healthcare VC Coverage, Commercial Banking, J.P. Morgan

Browse by topic

Contributors

Related insights